
Cognitive function and control of type 2 diabetes mellitus in young adults
Author(s) -
Satyajeet Roy,
Nami Kim,
Anjali Desai,
Mahathi Komaragiri,
Namrata Baxi,
Navinder Jassil,
Megan Blessinger,
Maliha Khan,
Robert Cole,
Nayan Desai,
Rocco Terrigno,
Krystal Hunter
Publication year - 2015
Publication title -
north american journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2250-1541
pISSN - 1947-2714
DOI - 10.4103/1947-2714.157627
Subject(s) - cognition , medicine , diabetes mellitus , hemoglobin , type 2 diabetes , type 2 diabetes mellitus , pediatrics , endocrinology , psychiatry
Type 2 diabetes mellitus (T2DM) has been associated with impairment of cognitive function. Studies show a strong negative correlation between the levels of glycosylated hemoglobin and cognitive function in adult patients above the mean age of 60 years. In healthy adults, age-related cognitive impairment is mostly reported after the age of 60 years, hence the decline in cognitive function can be a part of normal aging without diabetes. Since the majority of patients with diabetes are between the ages of 40 and 59 years, it is crucial to ascertain whether the levels of glycosylated hemoglobin negatively correlate with the levels of cognitive function scores in adult patients of age 60 years or younger, similar to the way it correlates in patients older than 60 years of age, or not.